Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30
(-1.91%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s advances with arm planning to initiate Phase 2 trial of CA-170
>>
Dr. Reddy’s arm planning to initiate Phase 2 trial of CA-170
>>
German Regulatory issues zero critical, six major observations to Dr Reddy’s Duvvada facility
>>
Dr. Reddy’s Laboratories launches Metaxalone Tablets in US market
>>
Dr. Reddy's launches Bupropion Hydrochloride Extended-Release Tablets in US
>>
Clarification sought from Dr Reddys Laboratories
>>
Dr. Reddy’s, Vivus settle long-pending patent litigation for Qsymia
>>
Dr. Reddy’s Laboratories trades in green on the bourses
>>
Dr. Reddy’s to reintroduce back pain-reliever Doan’s in US
>>
Dr. Reddy’s faces class action suit in US District Court
<<
<
84
85
86
...143
>
>>